Wall Street wasn't happy about Nastech Pharma's latest quarter, so Cramer brought Chairman, CEO and President Dr. Steven Quay on Mad Money to find out what was going on.
Watch the video to get Quay's outlook on Nastech's "multiple shots on goal" approach to business, the reason for Procter & Gamble's hold on a $5 million payment, and why the company's nasal delivery system will succeed where others haven't.
Questions for Cramer? firstname.lastname@example.org
Questions, comments, suggestions for the Mad Money website? email@example.com